메뉴 건너뛰기




Volumn 85, Issue 3, 2008, Pages 344-352

Increased risk of graft failure in kidney transplant recipients after a diagnosis of dyspepsia or gastroesophageal reflux disease

Author keywords

Dyspepsia; Gastro esophageal reflux disease; Gastrointestinal complications; Graft survival; Kidney transplantation; USRDS

Indexed keywords

CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

EID: 40049085792     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318160d4c4     Document Type: Article
Times cited : (11)

References (73)
  • 1
    • 0030321746 scopus 로고    scopus 로고
    • A multi-factor analysis of kidney graft outcomes at one and five years posttransplantation: 1996 UNOS Update
    • Gjertson DW. A multi-factor analysis of kidney graft outcomes at one and five years posttransplantation: 1996 UNOS Update. Clin Transpl 1996; 343.
    • (1996) Clin Transpl , pp. 343
    • Gjertson, D.W.1
  • 2
    • 26644469263 scopus 로고    scopus 로고
    • Tacrolimus versus cyclosporin as primary immunosuppression for kidney transplant recipients: Meta-analysis and meta-regression of randomised trial data
    • Webster AC, Woodroffe RC, Taylor RS, Chapman JR, Craig JC. Tacrolimus versus cyclosporin as primary immunosuppression for kidney transplant recipients: Meta-analysis and meta-regression of randomised trial data. BMJ 2005; 331: 810.
    • (2005) BMJ , vol.331 , pp. 810
    • Webster, A.C.1    Woodroffe, R.C.2    Taylor, R.S.3    Chapman, J.R.4    Craig, J.C.5
  • 3
    • 0034023906 scopus 로고    scopus 로고
    • Immunosuppressive agents in organ transplantation: Past, present, and future
    • Hong JC, Kahan BD. Immunosuppressive agents in organ transplantation: Past, present, and future. Semin Nephrol 2000; 20: 108.
    • (2000) Semin Nephrol , vol.20 , pp. 108
    • Hong, J.C.1    Kahan, B.D.2
  • 5
    • 20544469447 scopus 로고    scopus 로고
    • Enteric-coated mycophenolate sodium: Tolerability profile compared with mycophenolate mofetil
    • Behrend M, Braun F. Enteric-coated mycophenolate sodium: Tolerability profile compared with mycophenolate mofetil. Drugs 2005; 65: 1037.
    • (2005) Drugs , vol.65 , pp. 1037
    • Behrend, M.1    Braun, F.2
  • 6
    • 27144546807 scopus 로고    scopus 로고
    • Questionnaire-based evaluation of gastrointestinal disorders in de novo renal-transplant patients receiving either mycophenolate mofetil or enteric-coated mycophenolate sodium
    • Kamar N, Oufroukhi L, Faure P, et al. Questionnaire-based evaluation of gastrointestinal disorders in de novo renal-transplant patients receiving either mycophenolate mofetil or enteric-coated mycophenolate sodium. Nephrol Dial Transplant 2005; 20: 2231.
    • (2005) Nephrol Dial Transplant , vol.20 , pp. 2231
    • Kamar, N.1    Oufroukhi, L.2    Faure, P.3
  • 7
    • 23244451207 scopus 로고    scopus 로고
    • Gastrointestinal complications in renal transplant recipients
    • Ponticelli C, Passerini P. Gastrointestinal complications in renal transplant recipients. Transpl Int 2005; 18: 643.
    • (2005) Transpl Int , vol.18 , pp. 643
    • Ponticelli, C.1    Passerini, P.2
  • 8
    • 12144273473 scopus 로고    scopus 로고
    • Long-term outcome of gastrointestinal complications in renal transplant patients treated with mycophenolate mofetil
    • Hardinger KL, Brennan DC, Lowell J, Schnitzler MA. Long-term outcome of gastrointestinal complications in renal transplant patients treated with mycophenolate mofetil. Transpl Int 2004; 17: 609.
    • (2004) Transpl Int , vol.17 , pp. 609
    • Hardinger, K.L.1    Brennan, D.C.2    Lowell, J.3    Schnitzler, M.A.4
  • 9
    • 0042536429 scopus 로고    scopus 로고
    • Mycophenolate mofetil dose reduction and the risk of acute rejection after renal transplantation
    • Knoll GA, MacDonald I, Khan A, Van Walraven C. Mycophenolate mofetil dose reduction and the risk of acute rejection after renal transplantation. J Am Soc Nephrol 2003; 14: 2381.
    • (2003) J Am Soc Nephrol , vol.14 , pp. 2381
    • Knoll, G.A.1    MacDonald, I.2    Khan, A.3    Van Walraven, C.4
  • 10
    • 0037663784 scopus 로고    scopus 로고
    • The impact of mycophenolate mofetil dosing patterns on clinical outcome after renal transplantation
    • Pelletier RP, Akin B, Henry ML, et al. The impact of mycophenolate mofetil dosing patterns on clinical outcome after renal transplantation. Clin Transplant 2003; 17: 200.
    • (2003) Clin Transplant , vol.17 , pp. 200
    • Pelletier, R.P.1    Akin, B.2    Henry, M.L.3
  • 11
    • 1342325540 scopus 로고    scopus 로고
    • Enteric-coated mycophenolate sodium can be safely administered in maintenance renal transplant patients: Results of a 1-year study
    • Budde K, Curtis J, Knoll G, et al. Enteric-coated mycophenolate sodium can be safely administered in maintenance renal transplant patients: Results of a 1-year study. Am J Transplant 2004; 4: 237.
    • (2004) Am J Transplant , vol.4 , pp. 237
    • Budde, K.1    Curtis, J.2    Knoll, G.3
  • 12
    • 1342346699 scopus 로고    scopus 로고
    • Enteric-coated mycophenolate sodium is therapeutically equivalent to mycophenolate mofetil in de novo renal transplant patients
    • Salvadori M, Holzer H, de Mattos A, et al. Enteric-coated mycophenolate sodium is therapeutically equivalent to mycophenolate mofetil in de novo renal transplant patients. Am J Transplant 2004; 4: 231.
    • (2004) Am J Transplant , vol.4 , pp. 231
    • Salvadori, M.1    Holzer, H.2    de Mattos, A.3
  • 13
    • 33747494883 scopus 로고    scopus 로고
    • Mycophenolate mofetil dose reductions and discontinuations after gastrointestinal complications are associated with renal transplant graft failure
    • Bunnapradist S, Lentine KL, Burroughs TE, et al. Mycophenolate mofetil dose reductions and discontinuations after gastrointestinal complications are associated with renal transplant graft failure. Transplantation 2006; 82: 102.
    • (2006) Transplantation , vol.82 , pp. 102
    • Bunnapradist, S.1    Lentine, K.L.2    Burroughs, T.E.3
  • 14
    • 12344315234 scopus 로고    scopus 로고
    • North of England Dyspepsia Guideline Development Group, Newcastle upon Tyne UK, Centre for Health Services Research, University of Newcastle
    • North of England Dyspepsia Guideline Development Group. Dyspepsia: Managing dyspepsia in adults in primary care. Newcastle upon Tyne (UK): Centre for Health Services Research, University of Newcastle, 2004.
    • (2004) Dyspepsia: Managing dyspepsia in adults in primary care
  • 15
    • 27744571011 scopus 로고    scopus 로고
    • Guidelines for the management of dyspepsia
    • Talley NJ, Vakil N. Guidelines for the management of dyspepsia. Am J Gastroenterol 2005; 100: 2324.
    • (2005) Am J Gastroenterol , vol.100 , pp. 2324
    • Talley, N.J.1    Vakil, N.2
  • 16
    • 10644286465 scopus 로고    scopus 로고
    • Review article: Prevalence and epidemiology of gastrooesophageal reflux disease
    • Delaney BC. Review article: Prevalence and epidemiology of gastrooesophageal reflux disease. Aliment Pharmacol Ther 2004; 20(Suppl 8): 2.
    • (2004) Aliment Pharmacol Ther , vol.20 , Issue.SUPPL. 8 , pp. 2
    • Delaney, B.C.1
  • 17
    • 21844437954 scopus 로고    scopus 로고
    • Early experience with enteric-coated mycophenolate sodium in de novo kidney transplant recipients
    • Chang HR, Lin CC, Lian JD. Early experience with enteric-coated mycophenolate sodium in de novo kidney transplant recipients. Transplant Proc 2005; 37: 2066.
    • (2005) Transplant Proc , vol.37 , pp. 2066
    • Chang, H.R.1    Lin, C.C.2    Lian, J.D.3
  • 18
    • 0036307636 scopus 로고    scopus 로고
    • Upper gastrointestinal complications after renal transplantation: A 3-yr sequential study
    • Logan AJ, Morris-Stiff GJ, Bowrey DJ, Jurewicz WA. Upper gastrointestinal complications after renal transplantation: A 3-yr sequential study. Clin Transplant 2002; 16: 163.
    • (2002) Clin Transplant , vol.16 , pp. 163
    • Logan, A.J.1    Morris-Stiff, G.J.2    Bowrey, D.J.3    Jurewicz, W.A.4
  • 19
    • 0031001622 scopus 로고    scopus 로고
    • A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group
    • Pirsch JD, Miller J, Deierhoi MH, Vincenti F, Filo RS. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group. Transplantation 1997; 63: 977.
    • (1997) Transplantation , vol.63 , pp. 977
    • Pirsch, J.D.1    Miller, J.2    Deierhoi, M.H.3    Vincenti, F.4    Filo, R.S.5
  • 20
    • 33846980744 scopus 로고    scopus 로고
    • Increased prevalence of gastrointestinal symptoms associated with impaired quality of life in renal transplant recipients
    • Ekberg H, Kyllonen L, Madsen S, Grave G, Solbu D, Holdaas H. Increased prevalence of gastrointestinal symptoms associated with impaired quality of life in renal transplant recipients. Transplantation 2007; 83: 282.
    • (2007) Transplantation , vol.83 , pp. 282
    • Ekberg, H.1    Kyllonen, L.2    Madsen, S.3    Grave, G.4    Solbu, D.5    Holdaas, H.6
  • 21
    • 33750587517 scopus 로고    scopus 로고
    • Using GI-specific patient outcome measures in renal transplant patients: Validation of the GSRS and GIQLI
    • Kleinman L, Kilburg A, Machnicki G, et al. Using GI-specific patient outcome measures in renal transplant patients: Validation of the GSRS and GIQLI. Qual Life Res 2006; 15: 1223.
    • (2006) Qual Life Res , vol.15 , pp. 1223
    • Kleinman, L.1    Kilburg, A.2    Machnicki, G.3
  • 22
    • 0031893616 scopus 로고    scopus 로고
    • Reliability and validity of the Gastrointestinal Symptom Rating Scale in patients with gastroesophageal reflux disease
    • Revicki DA, Wood M, Wiklund I, Crawley J. Reliability and validity of the Gastrointestinal Symptom Rating Scale in patients with gastroesophageal reflux disease. Qual Life Res 1998; 7: 75.
    • (1998) Qual Life Res , vol.7 , pp. 75
    • Revicki, D.A.1    Wood, M.2    Wiklund, I.3    Crawley, J.4
  • 26
    • 0035955922 scopus 로고    scopus 로고
    • Prevalence of gastrointestinal symptoms associated with diabetes mellitus: A population-based survey of 15,000 adults
    • Bytzer P, Talley NJ, Leemon M, Young LJ, Jones MP, Horowitz M. Prevalence of gastrointestinal symptoms associated with diabetes mellitus: A population-based survey of 15,000 adults. Arch Intern Med 2001; 161: 1989.
    • (2001) Arch Intern Med , vol.161 , pp. 1989
    • Bytzer, P.1    Talley, N.J.2    Leemon, M.3    Young, L.J.4    Jones, M.P.5    Horowitz, M.6
  • 27
    • 0034716890 scopus 로고    scopus 로고
    • Prevalence, severity and associated features of gastro-oesophageal reflux and dyspepsia: A population-based study
    • Haque M, Wyeth JW, Stace NH, Talley NJ, Green R. Prevalence, severity and associated features of gastro-oesophageal reflux and dyspepsia: A population-based study. N Z Med J 2000; 113: 178.
    • (2000) N Z Med J , vol.113 , pp. 178
    • Haque, M.1    Wyeth, J.W.2    Stace, N.H.3    Talley, N.J.4    Green, R.5
  • 28
    • 33644886030 scopus 로고    scopus 로고
    • Detailed characterization of epidemiology of Uninvestigated Dyspepsia and its impact on Quality of Life among African-American as compared to Caucasians
    • Minocha A, Wigington W, Johnson W. Detailed characterization of epidemiology of Uninvestigated Dyspepsia and its impact on Quality of Life among African-American as compared to Caucasians. Am J Gastroenterol 2006; 101: 336.
    • (2006) Am J Gastroenterol , vol.101 , pp. 336
    • Minocha, A.1    Wigington, W.2    Johnson, W.3
  • 31
    • 17644416461 scopus 로고    scopus 로고
    • Epidemiology of gastro-oesophageal reflux disease: A systematic review
    • Dent J, El-Serag HB, Wallander MA, Johansson S. Epidemiology of gastro-oesophageal reflux disease: A systematic review. Gut 2005; 54: 710.
    • (2005) Gut , vol.54 , pp. 710
    • Dent, J.1    El-Serag, H.B.2    Wallander, M.A.3    Johansson, S.4
  • 32
    • 0033029057 scopus 로고    scopus 로고
    • Locke GR, 3rd, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ, 3rd. Risk factors associated with symptoms of gastroesophageal reflux. Am J Med 1999; 106: 642.
    • Locke GR, 3rd, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ, 3rd. Risk factors associated with symptoms of gastroesophageal reflux. Am J Med 1999; 106: 642.
  • 33
    • 4544296853 scopus 로고    scopus 로고
    • Risk factors for erosive esophagitis: Amultivariate analysis based on the ProGERD study initiative
    • Labenz J, Jaspersen D, Kulig M, et al. Risk factors for erosive esophagitis: Amultivariate analysis based on the ProGERD study initiative. Am J Gastroenterol 2004; 99: 1652.
    • (2004) Am J Gastroenterol , vol.99 , pp. 1652
    • Labenz, J.1    Jaspersen, D.2    Kulig, M.3
  • 34
    • 0026644820 scopus 로고
    • Oesophageal angina in patients with angina pectoris: A possible side effect of chronic therapy with nitroderivates and Ca-antagonists
    • Bortolotti M, Labriola E, Bacchelli S, et al. "Oesophageal angina" in patients with angina pectoris: A possible side effect of chronic therapy with nitroderivates and Ca-antagonists. Ital J Gastroenterol 1992; 24: 405.
    • (1992) Ital J Gastroenterol , vol.24 , pp. 405
    • Bortolotti, M.1    Labriola, E.2    Bacchelli, S.3
  • 35
    • 40049086244 scopus 로고    scopus 로고
    • Management of gastroesophageal reflux disease (GERD). In: System UoMH, ed: University of Michigan Health System, 2002.
    • Management of gastroesophageal reflux disease (GERD). In: System UoMH, ed: University of Michigan Health System, 2002.
  • 36
    • 0027529495 scopus 로고
    • The incidence of reflux oesophagitis. A study of endoscopy reports from a defined catchment area in Sweden
    • Loof L, Gotell P, Elfberg B. The incidence of reflux oesophagitis. A study of endoscopy reports from a defined catchment area in Sweden. Scand J Gastroenterol 1993; 28: 113.
    • (1993) Scand J Gastroenterol , vol.28 , pp. 113
    • Loof, L.1    Gotell, P.2    Elfberg, B.3
  • 37
    • 0036668686 scopus 로고    scopus 로고
    • Risk factors for the severity of erosive esophagitis in Helicobacter pylori-negative patients with gastroesophageal reflux disease
    • El-Serag HB, Johanson JF. Risk factors for the severity of erosive esophagitis in Helicobacter pylori-negative patients with gastroesophageal reflux disease. Scand J Gastroenterol 2002; 37: 899.
    • (2002) Scand J Gastroenterol , vol.37 , pp. 899
    • El-Serag, H.B.1    Johanson, J.F.2
  • 39
    • 0033567122 scopus 로고    scopus 로고
    • Mycophenolate mofetil in renal transplantation: 3-year results from the placebo-controlled trial. European Mycophenolate Mofetil Cooperative Study Group
    • Mycophenolate mofetil in renal transplantation: 3-year results from the placebo-controlled trial. European Mycophenolate Mofetil Cooperative Study Group. Transplantation 1999; 68: 391.
    • (1999) Transplantation , vol.68 , pp. 391
  • 40
    • 0034889041 scopus 로고    scopus 로고
    • Adverse gastrointestinal effects of mycophenolate mofetil: Aetiology, incidence and management
    • Behrend M. Adverse gastrointestinal effects of mycophenolate mofetil: Aetiology, incidence and management. Drug Saf 2001; 24: 645.
    • (2001) Drug Saf , vol.24 , pp. 645
    • Behrend, M.1
  • 41
    • 22244431879 scopus 로고    scopus 로고
    • Randomized calcineurin inhibitor cross over study to measure the pharmacokinetics of co-administered enteric-coated mycophenolate sodium
    • Kaplan B, Meier-Kriesche HU, Minnick P, et al. Randomized calcineurin inhibitor cross over study to measure the pharmacokinetics of co-administered enteric-coated mycophenolate sodium. Clin Transplant 2005; 19: 551.
    • (2005) Clin Transplant , vol.19 , pp. 551
    • Kaplan, B.1    Meier-Kriesche, H.U.2    Minnick, P.3
  • 42
    • 17844397187 scopus 로고    scopus 로고
    • Dose optimization of mycophenolate mofetil when administered with a low dose of tacrolimus in cadaveric renal transplant recipients
    • Squifflet JP, Backman L, Claesson K, et al. Dose optimization of mycophenolate mofetil when administered with a low dose of tacrolimus in cadaveric renal transplant recipients. Transplantation 2001; 72: 63.
    • (2001) Transplantation , vol.72 , pp. 63
    • Squifflet, J.P.1    Backman, L.2    Claesson, K.3
  • 43
    • 0029006409 scopus 로고    scopus 로고
    • Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection. European Mycophenolate Mofetil Cooperative Study Group. Lancet 1995; 345: 1321
    • Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection. European Mycophenolate Mofetil Cooperative Study Group. Lancet 1995; 345: 1321.
  • 44
    • 0032570310 scopus 로고    scopus 로고
    • Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: The Mycophenolate Mofetil Acute Renal Rejection Study Group
    • Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: The Mycophenolate Mofetil Acute Renal Rejection Study Group. Transplantation 1998; 65: 235.
    • (1998) Transplantation , vol.65 , pp. 235
  • 45
    • 39449096479 scopus 로고    scopus 로고
    • Significnant improvement of GI-Symptoms burden in African-American transplant recipients after conversion to EC-MPS
    • Bolin P, Tanriover B, Lynn M, et al. Significnant improvement of GI-Symptoms burden in African-American transplant recipients after conversion to EC-MPS. Transplantation 2006; 82 (1 Suppl 2): 514.
    • (2006) Transplantation , vol.82 , Issue.1 SUPPL. 2 , pp. 514
    • Bolin, P.1    Tanriover, B.2    Lynn, M.3
  • 46
    • 33744494308 scopus 로고    scopus 로고
    • Patient-reported gastrointestinal symptom burden and health-related quality of life following conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium
    • Chan L, Mulgaonkar S, Walker R, Arns W, Ambuhl P, Schiavelli R. Patient-reported gastrointestinal symptom burden and health-related quality of life following conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium. Transplantation 2006; 81: 1290.
    • (2006) Transplantation , vol.81 , pp. 1290
    • Chan, L.1    Mulgaonkar, S.2    Walker, R.3    Arns, W.4    Ambuhl, P.5    Schiavelli, R.6
  • 48
    • 0036138550 scopus 로고    scopus 로고
    • Gastrointestinal complications of transplant immunosuppression
    • Helderman JH, Goral S. Gastrointestinal complications of transplant immunosuppression. J Am Soc Nephrol 2002; 13: 277.
    • (2002) J Am Soc Nephrol , vol.13 , pp. 277
    • Helderman, J.H.1    Goral, S.2
  • 49
    • 0025364315 scopus 로고
    • The influence of immunosuppression on peptic ulceration following renal transplantation and the role of endoscopy
    • Steger AC, Timoney AS, Griffen S, Salem RR, Williams G. The influence of immunosuppression on peptic ulceration following renal transplantation and the role of endoscopy. Nephrol Dialysis Transplant 1990; 5: 289.
    • (1990) Nephrol Dialysis Transplant , vol.5 , pp. 289
    • Steger, A.C.1    Timoney, A.S.2    Griffen, S.3    Salem, R.R.4    Williams, G.5
  • 50
    • 26944462057 scopus 로고    scopus 로고
    • Viral infection in the renal transplant recipient
    • Kotton CN, Fishman JA. Viral infection in the renal transplant recipient. J Am Soc Nephrol 2005; 16: 1758.
    • (2005) J Am Soc Nephrol , vol.16 , pp. 1758
    • Kotton, C.N.1    Fishman, J.A.2
  • 51
    • 14044273016 scopus 로고    scopus 로고
    • Posttransplant diabetes mellitus and atherosclerotic events in renal transplant recipients: A prospective study
    • Ducloux D, Kazory A, Chalopin JM. Posttransplant diabetes mellitus and atherosclerotic events in renal transplant recipients: A prospective study. Transplantation 2005; 79: 438.
    • (2005) Transplantation , vol.79 , pp. 438
    • Ducloux, D.1    Kazory, A.2    Chalopin, J.M.3
  • 52
    • 33748674395 scopus 로고    scopus 로고
    • Gonzalez-Posada J, Hernandez D, Gen?s B, et al. Increased cardiovascular risk profile and mortality in kidney allograft recipients with post-transplant diabetes mellitus in Spain. Clinl Transplant 2006; 20: 650.
    • Gonzalez-Posada J, Hernandez D, Gen?s B, et al. Increased cardiovascular risk profile and mortality in kidney allograft recipients with post-transplant diabetes mellitus in Spain. Clinl Transplant 2006; 20: 650.
  • 54
    • 0036435793 scopus 로고    scopus 로고
    • Natural history of reflux esophagitis: What is the risk of progression and does it matter clinically?
    • Talley NJ. Natural history of reflux esophagitis: What is the risk of progression and does it matter clinically? J Gastroenterol Hepatol 2002; 17: 1247.
    • (2002) J Gastroenterol Hepatol , vol.17 , pp. 1247
    • Talley, N.J.1
  • 55
    • 33846556613 scopus 로고    scopus 로고
    • Gastroesophageal reflux disease as a cause of death is increasing: Analysis of fatal cases after medical and surgical treatment
    • Rantanen TK, Sihvo EI, Rasanen JV, Salo JA. Gastroesophageal reflux disease as a cause of death is increasing: Analysis of fatal cases after medical and surgical treatment. Am J Gastroenterol 2007; 102: 246.
    • (2007) Am J Gastroenterol , vol.102 , pp. 246
    • Rantanen, T.K.1    Sihvo, E.I.2    Rasanen, J.V.3    Salo, J.A.4
  • 57
    • 0032423479 scopus 로고    scopus 로고
    • Respiratory complications of gastrointestinal diseases
    • Young MA, Reynolds JC. Respiratory complications of gastrointestinal diseases. Gastroenterol Clin North Am 1998; 27: 721.
    • (1998) Gastroenterol Clin North Am , vol.27 , pp. 721
    • Young, M.A.1    Reynolds, J.C.2
  • 58
    • 0030768825 scopus 로고    scopus 로고
    • Comorbid occurrence of laryngeal or pulmonary disease with esophagitis in United States military veterans
    • El-Serag HB, Sonnenberg A. Comorbid occurrence of laryngeal or pulmonary disease with esophagitis in United States military veterans. Gastroenterology 1997; 113: 755.
    • (1997) Gastroenterology , vol.113 , pp. 755
    • El-Serag, H.B.1    Sonnenberg, A.2
  • 59
    • 0035282729 scopus 로고    scopus 로고
    • Aspiration pneumonitis and aspiration pneumonia
    • Marik PE. Aspiration pneumonitis and aspiration pneumonia. N Engl J Med 2001; 344: 665.
    • (2001) N Engl J Med , vol.344 , pp. 665
    • Marik, P.E.1
  • 60
    • 0034855410 scopus 로고    scopus 로고
    • Hospitalization with respiratory disease following hiatal hernia and reflux esophagitis in a prospective, population-based study
    • Ruhl CE, Sonnenberg A, Everhart JE. Hospitalization with respiratory disease following hiatal hernia and reflux esophagitis in a prospective, population-based study. Ann Epidemiol 2001; 11: 477.
    • (2001) Ann Epidemiol , vol.11 , pp. 477
    • Ruhl, C.E.1    Sonnenberg, A.2    Everhart, J.E.3
  • 61
    • 30144438575 scopus 로고    scopus 로고
    • Vancomycin-resistant enterococcal colonization and infection in liver transplant candidates and recipients: A prospective surveillance study.[see comment]
    • McNeil SA, Malani PN, Chenoweth CE, et al. Vancomycin-resistant enterococcal colonization and infection in liver transplant candidates and recipients: A prospective surveillance study.[see comment]. Clin Infect Dis 2006; 42: 195.
    • (2006) Clin Infect Dis , vol.42 , pp. 195
    • McNeil, S.A.1    Malani, P.N.2    Chenoweth, C.E.3
  • 63
    • 0036320158 scopus 로고    scopus 로고
    • Prevalence of Barrett's esophagus in asymptomatic individuals
    • Gerson LB, Shetler K, Triadafilopoulos G. Prevalence of Barrett's esophagus in asymptomatic individuals. Gastroenterology 2002; 123: 461.
    • (2002) Gastroenterology , vol.123 , pp. 461
    • Gerson, L.B.1    Shetler, K.2    Triadafilopoulos, G.3
  • 64
    • 0033580405 scopus 로고    scopus 로고
    • Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma
    • Lagergren J, Bergstrom R, Lindgren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999; 340: 825.
    • (1999) N Engl J Med , vol.340 , pp. 825
    • Lagergren, J.1    Bergstrom, R.2    Lindgren, A.3    Nyren, O.4
  • 66
    • 0032977480 scopus 로고    scopus 로고
    • Late renal allograft loss: Noncompliance masquerading as chronic rejection
    • Gaston RS, Hudson SL, Ward M, Jones P, Macon R. Late renal allograft loss: Noncompliance masquerading as chronic rejection. Transplant Proc 1999; 31: 21S.
    • (1999) Transplant Proc , vol.31
    • Gaston, R.S.1    Hudson, S.L.2    Ward, M.3    Jones, P.4    Macon, R.5
  • 67
    • 0034787396 scopus 로고    scopus 로고
    • The natural history of azathioprine compliance after renal transplantation
    • Nevins TE, Kruse L, Skeans MA, Thomas W. The natural history of azathioprine compliance after renal transplantation. Kidney Int 2001; 60: 1565.
    • (2001) Kidney Int , vol.60 , pp. 1565
    • Nevins, T.E.1    Kruse, L.2    Skeans, M.A.3    Thomas, W.4
  • 70
    • 9244232285 scopus 로고    scopus 로고
    • Chest pain in patients with cardiac and noncardiac disease
    • Sheps DS, Creed F, Clouse RE. Chest pain in patients with cardiac and noncardiac disease. Psychosom Med 2004; 66: 861.
    • (2004) Psychosom Med , vol.66 , pp. 861
    • Sheps, D.S.1    Creed, F.2    Clouse, R.E.3
  • 72
    • 34247502491 scopus 로고    scopus 로고
    • A three-month, prospective, open-label, two cohort study to investigate the efficacy, safety and tolerability of EC-MPS in combination with cyclosporin or tacrolimus in renal transplant recipients with GI intolerance
    • Tomlanovich S, Bolin P, Tanriover B, et al. A three-month, prospective, open-label, two cohort study to investigate the efficacy, safety and tolerability of EC-MPS in combination with cyclosporin or tacrolimus in renal transplant recipients with GI intolerance. Transplantation 2006; 82 (1 Suppl 3).
    • (2006) Transplantation , vol.82 , Issue.1 SUPPL. 3
    • Tomlanovich, S.1    Bolin, P.2    Tanriover, B.3
  • 73
    • 0036234316 scopus 로고    scopus 로고
    • The burden of selected digestive diseases in the United States
    • Sandler RS, Everhart JE, Donowitz M, et al. The burden of selected digestive diseases in the United States. Gastroenterology 2002; 122: 1500.
    • (2002) Gastroenterology , vol.122 , pp. 1500
    • Sandler, R.S.1    Everhart, J.E.2    Donowitz, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.